Royalty Pharma Plc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | 11.5% | 15.8% | 26.4% | 200.9% | 17.6% | 1.1% | 1.1% | 22.6% | 51.0% | 1.0% | 23.5% | 46.3% | 32.8% | 19.7% | 53.2% | 54.6% | 17.4% | 44.8% | 51.7% | 12.8% | 102.8% | 1.1% | 40.3% | 27.6% | 22.4% | 35.2% | 0.2% | 0.2% | 0.2% | 39.8% | 10.7% | |
| – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.8% | 60.2% | 89.4% | |
| – | – | – | – | – | – | – | – | – | – | 5.3% | 4.7% | 4.9% | 3.5% | 1.5% | 1.1% | 0.9% | 1.4% | 0.5% | 0.6% | 15.4% | 18.0% | 17.9% | 0.1% | 4.4% | 8.9% | 0.1% | 0.1% | 9.4% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 8.9% | 51.9% | 8.3% | 8.2% | 6.3% | 14.5% | 9.4% | |
| – | – | – | – | – | – | – | – | – | – | 5.6% | 6.6% | 5.5% | 5.0% | 7.6% | 8.4% | 9.4% | 8.8% | 7.5% | 8.1% | 8.3% | 8.0% | 9.2% | 9.7% | 8.8% | 12.9% | 12.5% | 8.9% | 10.7% | 9.9% | 10.2% | 10.2% | 10.0% | 11.4% | 19.5% | 31.1% | 19.5% | 26.4% | 25.2% | 24.0% | 23.8% | |
| – | – | – | – | – | – | – | – | – | – | 0.9% | 28.4% | -14.7% | -191.1% | 27.8% | 19.9% | 5.2% | 45.1% | 60.0% | -34.2% | 48.3% | 73.4% | 60.9% | 29.5% | 66.5% | 185.3% | 30.0% | 53.8% | 71.8% | -2.8% | 113.0% | 49.8% | -30.2% | 39.1% | 6.0% | 63.7% | 29.9% | 37.6% | -0.5% | 40.5% | 27.0% | |
| – | – | – | – | – | – | – | – | – | – | 99.1% | 71.6% | 114.7% | 291.1% | 72.2% | 80.1% | 94.8% | 54.9% | 40.0% | 134.2% | 51.7% | 26.6% | 39.1% | 70.5% | 33.5% | -85.3% | 70.0% | 46.2% | 28.2% | 102.8% | -13.0% | 50.2% | 130.2% | 60.9% | 94.0% | 36.3% | 70.1% | 62.4% | 100.3% | 19.7% | 62.3% | |
| – | – | – | – | – | – | – | – | – | – | 15.5% | 15.1% | 14.8% | 13.8% | 10.7% | 6.7% | 5.8% | 6.6% | 6.5% | 6.7% | 7.6% | 8.2% | 8.4% | 8.8% | 8.2% | 8.3% | 6.9% | 8.7% | 8.6% | 7.9% | 7.8% | 9.1% | 11.8% | 11.1% | 11.5% | 11.9% | 13.1% | 15.1% | 14.9% | 13.9% | 14.2% | |
| – | – | – | – | – | – | – | – | – | – | 91.1% | 39.1% | 94.8% | 316.2% | 21.8% | 117.8% | 115.9% | 64.1% | 27.7% | 145.4% | 37.9% | 9.3% | 22.8% | 91.7% | 38.4% | -107.8% | 74.4% | 65.3% | 22.8% | 120.4% | -0.8% | 36.2% | 142.8% | 56.3% | 76.3% | 15.7% | 72.9% | 57.2% | 74.3% | 12.1% | 53.2% | |
| – | – | – | – | – | – | – | – | – | – | 20.8% | 19.2% | 19.8% | 17.2% | 15.3% | 31.3% | 62.0% | -92.9% | 15.7% | 65.9% | 20.5% | 8.2% | 29.9% | 34.9% | 0.5% | 0.0% | 24.6% | 23.0% | 9.3% | 37.4% | -1.6% | 17.2% | 46.5% | 21.2% | – | 10.4% | 25.6% | 22.8% | 27.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | 84.5% | 33.2% | 88.1% | 310.5% | 14.2% | 86.5% | 54.0% | 29.9% | 12.1% | 79.4% | 17.4% | 1.4% | 9.2% | 56.8% | 24.9% | -80.6% | 49.8% | 42.3% | 13.4% | 82.9% | 0.8% | 19.0% | 96.3% | 35.1% | 41.9% | 5.2% | 47.3% | 34.4% | 46.8% | 2.7% | 32.1% | |
| – | – | – | – | – | – | – | – | – | – | 108.1% | 55.4% | 110.8% | 331.3% | 33.6% | 125.6% | 122.9% | 71.7% | 35.3% | 153.1% | 46.4% | 18.5% | 32.2% | 100.5% | 46.6% | -99.5% | 81.3% | 74.0% | 31.3% | 128.3% | 7.0% | 45.3% | 154.6% | 67.4% | 87.8% | 27.5% | 86.2% | 72.6% | 89.3% | 26.2% | 67.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.